Company/Division name | Pfizer |
Parent company | Pfeizer |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Total number of jobs (added or to be added): | 250 |
What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
Year reshoring announced: | 2022 |
Domestically, the work will be done: | In-house |
Capital investment ($): | 120 |
City reshored to: | Kalamazoo |
State(s) reshored to: | MI |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | antiviral COVID-19 pill Paxlovid |
What domestic positive factors made reshoring more attractive? | Higher productivity, Infrastructure, Skilled workforce availability/training, COVID-19 |